WASHINGTON, April 16, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the first quarter of 2015 on Wednesday, May 6, 2015, after the market closes.

The Company will host a conference call at 4:30 PM ET on Wednesday, May 6, 2015, during which Vanda management will discuss the first quarter 2015 financial results and other corporate activities. To participate in the conference call, please dial 1-800-708-4540 (domestic) or 1-847-619-6397 (international) and use passcode 39503340.

The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, May 6, 2015, beginning at 7:00 PM ET and will be accessible until Tuesday, May 12, 2015, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers. The passcode number is 39503340.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Jim Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2015-financial-results-on-may-6-2015-300067572.html

SOURCE Vanda Pharmaceuticals Inc.